chrisvoncsefalvay/vaers-outcomes huggingface dataset:
No additional adverse events reported; Expired dose of M-M-R II was administered to a patient today (06-DEC-2021); This spontaneous report was received from a licensed practical nurse referring to a patient of unknown age and gender. No patient's pertinent medical history, concurrent conditions, drug reactions or allergies, nor concomitant therapies were reported.       On 06-DEC-2021, the patient was vaccinated with an expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II), lot number S031483, expiration date 07-OCT-2021, (strength, dose, dose number, frequency, route, and anatomical location), for prophylaxis (expired product administered). the reporter stated that the measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) was stored properly through the time of vaccination. No adverse events were reported.
Received a Moderna Covid-19 vaccine vial on 31 Jan 2021 and the placed it in the refrigerator on the same day and administered on 10 Mar 2022; Administered with the vaccine beyond the 30 day use by date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered with the vaccine beyond the 30 day use by date) and PRODUCT STORAGE ERROR (Received a Moderna Covid-19 vaccine vial on 31 Jan 2021 and the placed it in the refrigerator on the same day and administered on 10 Mar 2022) in a 19-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 045L21A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2022 at 4:59 PM, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 10-Mar-2022 at 4:59 PM,  after starting mRNA-1273 (Spikevax), the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered with the vaccine beyond the 30 day use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Received a Moderna Covid-19 vaccine vial on 31 Jan 2021 and the placed it in the refrigerator on the same day and administered on 10 Mar 2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered with the vaccine beyond the 30 day use by date) and PRODUCT STORAGE ERROR (Received a Moderna Covid-19 vaccine vial on 31 Jan 2021 and the placed it in the refrigerator on the same day and administered on 10 Mar 2022) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported. A nurse practitioner reported a vaccine administration error. They stated that they received a Moderna Covid-19 vaccine vial on 31 Jan 2021 and placed it in the refrigerator on the same day ,specific time was unknown. They administered the vaccine to patient beyond the 30 days use by date. The patient did not reported any adverse events. Treatment information was not reported.
11:45 AM:  Developed itchy rash on R chest, which spread to R neck and both cheeks.  Then chest felt tight, used albuterol inhaler.  Wheezing followed, and patient take to ED.
consistent drowsiness that persists to this day and it has been weeks.; upper arm sore; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 40 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 10Aug2021 11:30 (Lot number: FC3180) at the age of 40 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 2021, outcome "recovered" (2021), described as "upper arm sore"; SOMNOLENCE (non-serious) with onset 11Aug2021, outcome "not recovered", described as "consistent drowsiness that persists to this day and it has been weeks.".  Additional information: Upper arm  sore  was went away in 48 hours.The patient stated that she can't drive and stay in her house and do certain things. She was asking if this was a normal reaction after receiving the Pfizer Covid Vaccine. She did not experience the drowsiness until receiving the Pfizer Covid Vaccine. None of additional Vaccines Administered on Same Date of the Pfizer Suspect. Any adverse event does not required to visit to Emergency Room or Physician Office. The patient did not taken any other vaccinations within four weeks prior to the first administration date of the suspect vaccine(s).Patient does not had any Medical History (including any illness at time of vaccination).   Follow-Up (13Sep2021): Follow-up attempts are completed. No further information is expected.  No follow-up attempts are possible. No further information is expected.
Pt recv vax on 10/5/98; on same day pt exp hives; tx=Prednisone
Several hours after my shot I felt lethargic, muscle aches and mild itching.I was ok the next day but on the 23rd of January I developed a mildly itchy bullseye rash 2 to 3 inches wide at injection site with what appeared to be a small bump that I had  first day also.I have felt mild itchness at injection si te and throughout body. Today I'm still mildly itchy but rash is improving.
One day following vax, patient developed inject site rxn of induration, swelling, itching, redness, and warmth. This is 1 of 8 employees of this facility to develop an injection site rxn. with lot# 4978139
Pt experienced a large erythemic area with edema, tenderness and warmth. Pt prescribed prednisone, periactin and cool soaks.
On about 09/28/2022 while traveling with a large group, we all started to have a very sore throat, runny nose, coughing. Arrived home on 10/2/2022 and took a Covid Test, it was immediately positive.  There were several (12 or so) of us on the trip, we all had the same symptoms and were all sick.  About 1/2 tested covid positive, and the other 1/2 negative.  Some with symptoms even tested negative with a PCR test.
The Medical Assistant reported a temperature excursion for refrigerated vaccine.; This spontaneous report was received from a Medical Assistant referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant medications, and historical drugs were not reported.  On 12-MAR-2021, the patient was vaccinated with an improperly stored dose of hepatitis rotavirus vaccine, live, oral, pentavalent(ROTATEQ) dose 1 (units not provided), per oral route (strength, dose #, frequency, and anatomical location were unknown) with lot # 1691301 and expiration date 12-DEC-2021 for prophylaxis.The patient was asyntomatic.  The administered dose of vaccine experience the temperature excursion on one of these dates, 22-FEB-2021, 25-FEB-2021, 02-MAR-2021, 05-MAR-2021, 09-MAR-2021, 15-MAR-2021, and 19-MAR-2021, of 35.6, 35.7, or 35.9  degrees Fahrenheit for 15 minutes; on 17-MAR-2021, the temperature excursion of 35.7 degrees Fahrenheit for 30 minutes;  on 18-MAR-2021 and 28-MAR-2021, of 35.2 and 35.9 degrees Fahrenheit for 45 minutes; on 25-MAR-2021, of 35.2 degrees Fahrenheit for 4 hours and 15 minutes; on 26-MAR-2021, of 35.4 degrees Fahrenheit for 2 hours and 45 minutes; or on 27-MAR-2021, of 35.9 degrees Fahrenheit 1 hour and 30 minutes.  There was no digital data logger involved, and no previous temperature excursion. The Vaccines for Children (VFC) program did an audit, and they were unaware of the excursions.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2105USA002850: US-009507513-2105USA003496: US-009507513-2105USA003497: US-009507513-2105USA003498: US-009507513-2105USA003499: US-009507513-2105USA003500: US-009507513-2105USA003501: US-009507513-2105USA003502: US-009507513-2105USA003503: US-009507513-2105USA003504: US-009507513-2105USA003505: US-009507513-2105USA003506: US-009507513-2105USA003507: US-009507513-2105USA003508: US-009507513-2105USA003509: US-009507513-2105USA003510: US-009507513-2105USA003511: US-009507513-2105USA003512: US-009507513-2105USA003513: US-009507513-2105USA003514: US-009507513-2105USA003515: US-009507513-2105USA003516: US-009507513-2105USA003517: US-009507513-2105USA003518: US-009507513-2105USA003519: US-009507513-2105USA003520: US-009507513-2105USA003521: US-009507513-2105USA003522: US-009507513-2105USA003523: US-009507513-2105USA003524: US-009507513-2105USA003525: US-009507513-2105USA003526: US-009507513-2105USA003527: US-009507513-2105USA003528: US-009507513-2105USA003529: US-009507513-2105USA003530: US-009507513-2105USA003531: US-009507513-2105USA003532: US-009507513-2105USA003533: US-009507513-2105USA003534: US-009507513-2105USA003535: US-009507513-2105USA003536: US-009507513-2105USA003537: US-009507513-2105USA003538: US-009507513-2105USA003539: US-009507513-2105USA003540: US-009507513-2105USA003541: US-009507513-2105USA003542: US-009507513-2105USA003543:
Fever on evening of second vaccine - highest was 100 - Fever between 98-99.6; Body aches throughout body Headache; Body aches throughout body Headache; Chills; This is a spontaneous report from a contactable Other HCP. This 56-year-old female Other HCP (patient) reported for herself that she received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot unknown: EL3246), via intramuscular at left arm on 12Jan2021 09:30AM at single dose for COVID-19 immunization. Medical history included known allergies: penicillin. Concomitant drugs included ascorbic acid (VITAMIN C). Historical vaccine included the first dose of BNT162B2 (Lot number: EH9899) on 22Dec2020 10:30AM via intramuscular at left arm for COVID-19 immunization. No other vaccine in four weeks. No COVID prior vaccination. No COVID tested post vaccination. On 12Jan2021 08:00pm, patient had fever on evening of second vaccine -highest was 100 -Fever between 98-99.6 next day and evening, body aches throughout body, headache, chills, fever gone after 40 hours or so. No treatment for AE. Outcome of events was recovered in Jan2021.
Client was being seen for Well Child Med Home Visit at Dr office. 15 minutes after receiving vaccine, client experienced "burning" at injection sites. Exam noted mild swelling and redness just around band aids over injection site on both sites. Redness and mild swelling expanded to approximately 8 cm over period of 5 minutes. Client denied any other discomfort or symptoms during event. Benadryl 25 mg Im administered at 11:00. Signs and symptoms of reaction alleviated in 20 minutes. Client was discharged to Mother s care at 11:40 in stable condition without s/s of redness or swelling at affected sites.
Pt received DTaP, PPV vax's on 2/12/03 on left leg. On 2/13/03, mother noticed 2 erythematous papules at inject site. Fever 101.8 on same day.
Parent reports that entire left upper thigh seems swollen 1-1/2 times normal size, swollen to but not including knee.  Rest of thigh blotchy. Painful.  Afebrile.  Sent for evaluation, treated with Keflex.
Information has been received from a physician concerning a 74 year old female with allergies to codeine and ciprofloxacin hydrochloride (CIPRO) and no other medical history who on 18-NOV-2006 was vaccinated SC in the arm with a dose of varicella-zoster virus vaccine live. Concomitant vaccination in the other arm on the same day included a dose of Pneumovax 23. Other concomitant medication included estrogens, conjugated (PREMARIN). On 20-NOV-2006, the patient developed a swollen right deltoid muscle and moderate erythema and swelling over the right elbow to mid forearm area. Unspecified medical attention was sought. The patient was told to have warm soaks in the shower, take over-the-counter nonsteroidal anti-inflammatory drugs, two tablets TID and diphenhydramine hydrochloride (BENADRYL) 25 mg daily BID. No diagnostic laboratory tests were performed. It was noted that the reaction on the arm was the one in which varicella-zoster virus vaccine live was given. The patient recovered on an unspecified date. A product quality complaint was not involved. The patient's experience was considered to be an other important medical event by the reporter. Additional information has been requested.
I noticed a few hours after the vaccine that my left upper eyelid was swollen, itchy and painful. I had experienced this with previous COVID 19 vaccines but not to this extent. I am currently scheduled to visit the Ophthalmologist for further testing.
Chills; Body aches/ body aches were most intense around my hips; Extreme fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 35-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the left arm on 23Apr2021 at 13:15 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history included hashimotos. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration on an unknown date in Mar2021 as a single dose for COVID-19 immunisation. On 24Apr2021, the patient experienced chills, body aches, extreme fatigue. Body aches were most intense around her hips. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, body aches, body aches were most intense around hips and extreme fatigue was recovering at the time of this report.  No follow-up attempts are possible. No further information is expected.
Day of shots, sleepiness, reduced feeding time form 20/30 minutes to 10-15. Started diarrhea that day through 2/5/02, pt had diarrhea for 4 weeks 6-7 times day (orig 1 X day). No fever 99.
Initial information was received on 17 October 2008 from a health care professional.  A 39 year old female patient with a latex allergy received a right deltoid intramuscular injection of ADACEL (lot number C2927AA) on 06 October 2008.  On 06 October 2008 the patient reported that she "passed out" after she received the vaccination.  No further information was provided.  The patient's recovery status was not reported.  List of Documents held by Sender: None.
C/o numbness and tingling in R arm and hand. Stiffness in lower extremities. Flu vaccine was injected in left arm.
Patient began to experience seizure activity(shaking and verbalized didn't feel well and sensed seizure coming on) during the 15 min observation period after her 2nd vaccine.
This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a 66-year-old female patient who received SHINGRIX for prophylaxis. On 22nd January 2019, the patient received the 1st dose of SHINGRIX (intramuscular). On 22nd January 2019, less than a day after receiving SHINGRIX, the patient experienced pain in arm. On 23rd January 2019, the patient experienced influenza-like symptoms, light headedness and fever. On an unknown date, the outcome of the influenza-like symptoms, light headedness and fever were recovered/resolved and the outcome of the pain in arm was not recovered/not resolved. It was unknown if the reporter considered the influenza-like symptoms, light headedness, fever and pain in arm to be related to SHINGRIX. Additional details were reported as follows: The patient received SHINGRIX on right arm. On 23rd January 2019, 1 day after vaccination the patient experienced flu-like symptoms, lightheaded, fever, and injection site arm pain after SHINGRIX. At the time of this report, the arm pain at injection site was described as arm soreness. The reporter consented to follow up.
Fever (99.9 Fahrenheit); Backache; Headache; Very fatigued; This is a spontaneous report from a contactable consumer. A 33-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the right arm on 10Apr2021 (at the age of 33-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021, the patient experienced fever (99.9 Fahrenheit), backache, headache and very fatigued. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. It was unknown whether the therapeutic measures were taken as a result of the events. On 13Apr2021, the patient underwent temperature test and the result was 99.9 Fahrenheit. The clinical outcome of the events fever (99.9 Fahrenheit), backache, headache and very fatigued was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Area red and swollen; itchy; noted increase in temperature; size of welt increased to 3x4 inches when seen in Urgent care on 6/8; had hives, increase in itching, temp; Give steroid shot and steroid pack; reports better 6/9 7:30 am.
Information has been received from a healthcare worker concerning a 65 year old male patient who had experienced an unspecified allergic reaction after received a dose of PNEUMOVAX (lot # 663012/1163X). The patient sought medical attention through a office call. Follow up information indicated that the patient also experienced a spot at the injection site with a rash (at the injection site). Follow up information received on 06-APR-2009 from a health professional stated that it was a postal service employee who complained on 29-OCT-2008 of reaction to injection, the patient was complained of redness, heat and swelling at the injection site. The patient had recovered. This is one of three reports from the same source. Additional information has been requested.
This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (receiving the vaccine she has not been hungry) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced DECREASED APPETITE (receiving the vaccine she has not been hungry). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DECREASED APPETITE (receiving the vaccine she has not been hungry) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications reported.
Onset of urticarial erythematous rash on left forearm on 4/5/2021, then had generalized itching on body and intermittent hives.
The day (Dec. 24th) after Covid vaccine patient had bad headache, felt very sluggish and nauseated x3d. 4th d, patient's eyes started turning red and burning as well as a rash on face.
Nine weeks after I got my third dose of the vaccine, I had an Atrial Fibrillation attack that lasted for 5 days. It happened on 01/22/2022 and lasted for 5 days. My Oncologist noticed that my Rhythm was not right and I was short of breath. I was having shortness of breath and it took me a while to recover. I saw my Cardiologist and my Heart Rhythm had returned to normal. I had a history of Atrial Fibrillation, and I had an Ablation in July of 2019. About 18 months later I had a Cardioversion to stabilize my heart rate in January of 2021. I am scheduled for another Ablation on 05/11/2022.
Developed Type 1 Diabetes at age 43. This is the 10th case of type 1 in adults that service members have reported. Will go to serum repository to see if she had the autoantibodies before receiving the vaccine. If she did or did not, it still does not prove causality. Symptoms: Fatigue, Malaise >60 Days, Lethargic, Weight loss, unexpected, Weakness, Nausea w/o vomiting, polydipsia, polyuria. 10/15/09 Medical records received for dates 5/05/09 to 10/08/09. DX: DM 1. Presenting symptoms: Pt believes her DX of DM 1  is a result of receiving vaccines. Denies any family history and denies any previous symptoms except frequent urination. Pt was seen in 11/08 and 12/08 and glucose levels were elevated. In Dec. 08, pt admitted to ICU for DKA. OV 5/5/09 DX: DM 1 f/u, Bacterial vaginosis, congenital deformity hip. OV 8/4/09 and 10/8/09 DX: f/u DM 1.
Pt lost consciousness for about 10 seconds; pts eyes "rolled back"; paramedics administered oxygen; EKG performed dx "vasovagal episode"; Blood specimens taken to check for diabetes & kidney func;
Myalgia, Arthralgia, Fever, chills, injection site pain Narrative:
pt recv vax 16DEC96 & 7APR97 pt exp vaccine failure/chickenpox & was dx w/mild varicella;
Administered at 11:39 During observation period Pt reports metallic taste in mouth PO2 97 Pulse 70
Red face without itching. I spoke with the Pharmacy and she recommended that I buy Benadryl 25mg. and will take one every 6 hours. At the same pharmacy around 11:20 am I took the first pill and the second at 5:20 pm.  After taking the first dose I felt better and have been doing well for the rest of the day.
Pt complained of tinging, heaviness in tongue. No drooling. No CP has some shortness of breath. No wheezing. Pulse ox 96% on RA. HR-78/min Lungs were clear. Pt given Benaydryl 25mg 1 tab by mouth. Pt given solumedrol 40mg IM pt showed improvement in signs and symptoms. BP 120/80
swollen tender breasts and menstrual spotting, while taking continous OCP for years and no spotting
1/7/2020 in am-  injection site size of a quarter, red, hot to touch, itchy, painful.  Upper lip itchy for 3 hours.  Late afternoon developed joint pain, muscle aches, fatigue, chills, headache, nausea. 1/8/2020 3am  injection site size of 50 cent piece , red, hot to touch, itchy, painful , small bumps on upper arm and upper chest.   Chills, headache, joint pain, muscle aches, fatigue, nausea and diarrhea
PATIENT RECEIVED FLU SHOT AT APPROX. 11:58AM AND 10 MINUTES AFTER ADMINISTRATION, PATIENT PRESENT WITH URTICARIA ONLY ON FACE. 2 ML OF BENADRYL WAS ADMINISTERED TO PATIENT AT 12:10PM AND AN ADDITIONAL 1 ML WAS ADMINISTERED AT 12:18PM. PATIENT WAS OBSERVED IN OFFICE FOR 20 MINUTES, URTICARIA RESOLVED.